Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

NASDAQ:CLDX

Overview | Financials
Company Name Celldex Therapeutics, Inc.
Symbol CLDX
Currency USD
Price 28.74
Market Cap 1,905,105,624
Dividend Yield 0%
52-week-range 22.11 - 53.18
Industry Biotechnology
Sector Healthcare
CEO Mr. Anthony S. Marucci M.B.A.
Website https://www.celldex.com

An error occurred while fetching data.

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds

Related Stocks

Pacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc.

PACB

1.9 USD

Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

CLOV

4.18 USD

Prothena Corporation plc logo

Prothena Corporation plc

PRTA

17.06 USD

Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc.

CTKB

5.14 USD

Exscientia plc logo

Exscientia plc

EXAI

5.06 USD

Veracyte, Inc. logo

Veracyte, Inc.

VCYT

34.31 USD

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

NXGN

23.94 USD

P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII

0.479 USD

Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc.

ZNTL

3 USD

Financials

Numbers are in millions USD

Numbers are in millions USD